Co-localization of β1,6-branched oligosaccharides and coarse melanin in macrophage-melanoma fusion hybrids and human melanoma cells in vitro

Pigment Cell Research

Volumn 17, Issue 3, 2004, Pages 281-288

  Rupani, Reena ^a   Handerson, Tamara ^a   Pawelek, John ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coarse melanin; GnT V; In vitro models; Melanoma; Metastasis

Indexed keywords

MELANIN; OLIGOSACCHARIDE; MELANOCYTE LINEAGE SPECIFIC ANTIGEN GP100; MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100; MEMBRANE PROTEIN; PROTEIN; TUMOR PROTEIN;

ARTICLE; CANCER CELL; ELECTRON MICROSCOPY; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MELANOMA; MELANOMA CELL; METASTASIS; PHENOTYPE; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; HYBRID CELL; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; HUMANS; HYBRID CELLS; MACROPHAGES; MELANINS; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM PROTEINS; OLIGOSACCHARIDES, BRANCHED-CHAIN; PROTEINS;

EID: 2642575686     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2004.00148.x     Document Type: Article

References (57)

1. Chakraborty AK, Pawelek JM. GNT-V, macrophages, and cancer metastasis: a common link. Clin Exp Metastasis 2003;20:365-373
2. Fukuda M, Spooncer E, Oates JE, Dell A, Klock JC. Structure of sialylated fucosyl lactosaminoglycan isolated from human granulocytes. J Biol Chem 1984;25:10925-10935
3. Dennis JW, Granovsky M, Warren CE. Glyocprotein glycosylation and cancer progression. Biochim Biophys Acta 1999;1473:21-34
4. Handerson T, Pawelek J. β1,6-branched oligosaccharides and coarse vesicles: a common and pervasive phenotype in melanoma and other human cancers. Cancer Res 2003;63:5363-5369
5. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nature Med 2000;6:306-312
6. Van den Eijenden DH, Koenderman AH, Schiphorst W. Biosynthesis of blood group i-active polylactosaminoglycans. J Biol Chem 1988;263:12461-12471
7. Cummings RD, Kornfeld S, Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized phaseolus vulgaris leukoagglutinating and phytoagglutinating lectins. J Biol Chem 1982;257:11230-11234
8. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW. β1, 6-branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 1991;51:718-723
9. Seelentag WKF, Li W, Schmitz SH, Metzger U, Aeberhard P, Heitz PU, Roth J. Prognostic value of β1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res 1998;58:5559-5564
10. Murata K, Miyoshi E, Kameyama M, Ishikawa O, Kabuto T, Sasaki Y, Hiratsuka M, Ohigashi H, Ishiguro S, Ito S, Honda H, Takemura F, Taniguchi N, Imaoka S. Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin Cancer Res 2000;6:1772-1777
11. Dennis JW, Laferte S. Oncodevelopmental expression of GlcNacβ1-6Manα1-6Manβ1-branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res 1989;49:945-950
12. Yamamoto H, Swoger J, Greene S, Saito JH, Sweeley C, Leestma J, Mkrdichian E, Cerullo L, Nishikawa A, Ihara Y, Taniguchi N, Moskal JR. β1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity. Cancer Res 2000;60:134-142
13. Heffernant M, Lotan R, Amos B, Palcic M, Takano R, Dennis JW. Branching β1-6-N-acetylglucosaminetransferases and polylactosamine expression in mouse F9 teratocarcinoma cells and differentiated counterparts. J Biol Chem 1993;268:1242-1251
14. Fukuda M. Lysosomal membrane glycoproteins. J Biol Chem 1991;15:21327-21330
15. Damus NM, Lobel P, Kornfeld S. Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem 1989;264:12115-12118
16. Leppa S, Heino J, Jalkanen M. Increased β1,6-branched N-glycans on β1 integrins affects interaction of transformed S115 mammary epithelial cells with laminin-1. Cell Growth Differ 1995;6:853-861
17. 1 integrin clustering and stimulates cell migration. Cancer Res 2002;62:6837-6845
18. 1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line. Mol Cancer Ther 2003;2:1207-1214
19. Guo H-B, Lee I, Kamar M, Pierce M. N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways. J Biol Chem 2003;278:52412-52424
20. Ihara S, Miyoshi E, Ko JH, Murata K, Nakahara S, Honke K, Dickson RB, Lin CY, Taniguchi N. Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding β1,6 GlcNAc branching. J Biol Chem 2002;277:16960-16967
21. Ihara S, Miyoshi E, Nakahara S, Sakiyama H, Ihara H, Akinaga A, Honke K, Dickson RB, Lin CY, Taniguchi N. Addition of β1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin. Glycobiology 2004;14:139-146
22. Sodi SA, Chakraborty AK, Platt JT, Kolesnikova N, Rosemblat S, Keh-Yen A, Bolognia JL, Rachkovsky ML, Orlow SJ, Pawelek JM. Melanoma x macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: altered N-glycosylation as an underlying mechanism. Pigment Cell Res 1998;11:299-309
23. Pawelek JM, Chakraborty AK, Rachkovsky ML, Orlow SJ, Bolognia JL, Sodi SA. Altered N-glycosylation in macrophage x melanoma fusion hybrids. Cell Mol Biol 2000;45:1011-1027
24. Rachkovsky MS Sodi S, Chakraborty A, Avissar Y, Bolognia J, Madison J, Bermudes D, Pawelek J. Enhanced metastatic potential of melanoma x macrophage fusion hybrids. Clin Exp Metastasis 1998;16:299-312
25. Rachkovsky M, Pawelek J. Acquired melanocyte stimulating hormone-inducible chemotaxis following macrophage fusion with Cloudman S91 melanoma cells. Cell Growth Differ 1999;10:515-524
26. Pawelek JM. Tumor cell hybridization and metastasis revisited. Melanoma Res 2000;10:507-514
27. Chakraborty A, Sodi S, Rachkovsky M, Kolesnikova N, Platt J, Bolognia J, Pawelek J. A spontaneous murine melanoma lung metastasis comprised of host × tumor hybrids. Cancer Res 2000;60:2512-2519
28. Chakraborty AK, Pawelek JM, Ikeda Y, Miyoshi E, Kolesnikova N, Funasaka Y, Ichihashi M, Tanaguchi N. Macrophage fusion upregulates N-acetyl-glucosaminyltransferase V, β1,6-branching, and metastasis in Cloudman S91 mouse melanoma cells. Cell Growth Differ 2001;12:623-630
29. Crowson AN, Magro CM, Mihm MC Jr Malignant melanoma with prominent pigment synthesis: "Animal-type" melanoma: a clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis. Hum Pathol 1999;30:543-550
30. Clark WH, Mastangelo MJ, Ainsworth AM, Berd D, Bellet RE, Bernardino EA. Current concepts of the biology of human cutaneous malignant melanoma. Adv Cancer Res 1977;24:267-338
31. Hariri M, Millane G, Guimond M, Guay G, Dennis JW, Nabi JR. Biogenesis of multilamellar bodies via autophagy. Mol Biol Cell 2000;11:255-268
32. Houghton AN, Real FX, Davis LF, Cordon-Cardo C, Old LJ. Phenotypic heterogeneity of melanoma: relation to the differentiation program of melanoma cells. J Exp Med 1987;165:812-829
33. Baba M, Takeshige K, Baba N, Ohsumi Y. Ultrastructural analysis of the autophagic process in yeast: detection of autophagosomes and their characterization. J Cell Biol 1994;124:903-913
34. x as a new tumor-associated antigen. Cancer Res 1984;44:5279-5285
35. Mitoma J, Petryniak B, Hiraoka N, Yeh JC, Lowe JB, Fukuda M. Extended core 1 and core 2 branched O-glycans differentially modulate Sialyl Lewis x-type L-selectin ligand activity. J Biol Chem 2003;278:9953-9956
36. Phillips ML, Nudelman E, Gaeta FCA, Perez M, Singhal AK, Hakomori S, Paulson JC. ELAM1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl LeX. Science 1990;250:1130-1132
37. Walz G, Aruffo A, Kolanus W, Bevilacqua M, Seed B. Recognition by ELAM1 of the sialyl LeX determinant on myeloid and tumor cells. Science 1990;250:1132-1135
38. Mishima Y. Cellular and subcellular differentiation of melanin phagocytosis and synthesis by lysosomal and melanosomal activity. J Invest Dermatol 1966;46:70-75
39. Hirone T, Nagai T, Matsubara T, Fukushiro R. Human malignant melanomas of the skin and their pre-existing conditions. In: Kawamura T, Fitzpatrick TB, Seiji M, eds. Biology of Normal and Abnormal Melanocytes. Tokyo: University Park Press; 1971. pp. 329-349
40. Cesarini JP. Recent advances in the ultrastructure of malignant melanoma. Rev Europ Etudes Clin Et Biol 1971;16:316-322
41. Klug H, Gunther W. Ultrastructural differences in human malignant melanomata. Br J Dermatol 1972;86:395-407
42. Horikoshi T, Jimbow K, Sugiyama S. Comparison of macromelanosomes and autophagic giant melanosome complexes in nevocellular nevi, lentigo simplex and malignant melanoma. J Cutan Pathol 1982;9:329-339
43. Astarie-Dequeker C, N'Diaye EN, Le Cabec V, Rittig MG, Prandi J, Maridonneau-Parini I. The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. Infect Immun 1999;67:469-477
44. Astarie-Dequeker C, Carreno S, Cougoule C, Maridonneau-Parini I. The protein tyrosine kinase Hck is located on lysosomal vesicles that are physically and functionally distinct from CD63-positive lysosomes in human macrophages. J Cell Sci 2002;115:81-89
45. Voorhout WF, Veenendaal T, Haagsman HP, Weaver TE, Whitsett JA, Van Golde LMG, Geuze HJ. Intracellular processing of pulmonary surfactant protein B in an endosomal/lysosmal compartment. Amer J Physiol 1992;263:479-486
46. Vischer UM, Wagner DD. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 1993;82:1184-1191
47. Barrio M, Bravo AI, Portela P, Hersey P, Mordoh J. A new epitope on human melanoma-associated antigen CD63/ME491 expressed by both primary and metastatic melanoma. Hybridoma 1998;17:355-364
48. Atkinson B, Ernst CS, Ghrist BFD, Herlyn M, Blaszcyk M, Ross AH, Herlyn D, Steplewski Z, Koprowski H. Identification of melanoma-associated antigens using fixed tissue screening of antibodies. Cancer Res 1984;44:2577-2581
49. Atkinson B, Ernst CS, Ghrist BFD, Ross AH, Clark WH, Herlyn M, Herlyn D, Maul G, Steplewski Z, Koprowski H. Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors. Hybridoma 1985;4:243-255
50. Smith M, Bleijs R, Radford K, Hersey P. Immunogenicity of CD63 in a patient with melanoma. Melanoma Res 1997;7:S163-S170
51. Sho M, Adachi M, Taki T, Hashida H, Korishi T, Huang CL, Ikeda N, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 1998;79:509-516
52. Huang CI, Kohnno N, Ogawa E, Adachi M, Taki T, Miyake M. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol 1998;153:973-983
53. Kushimoto T, Valencia JC, Costin G-E, Toyofuku K, Watabe H, Yasumoto K, Rouzaud F, Vieira WD, Hearing VJ. The melanosome: an ideal model to study cellular differentiation. Pigment Cell Res 2003;16:237-244
54. Basrur V, Yang F, Kushimoto T, Higashimoto Y, Yasumoto K, Valencia JC, Muller J, Vieira WD, Watabe H, Shabanowitz J, Hearing VJ, Hunt DF, Appella E. Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. J Proteome Res 2003;2:69-79
55. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J 1997;11:428-442
56. Radford KJ, Thome RF, Hersey P. Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 1997;158:3353-3358
57. Radford KJ, Thome RF, Hersey P. CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. Biochem Biophys Res Commun 1996;222:13-18